Cambia Approval History 
- FDA approved: Yes (First approved June 17th, 2009)
- Brand name: Cambia
- Generic name: diclofenac potassium
- Previous name: PRO-513
- Company: Kowa Pharmaceuticals America, Inc.
- Treatment for: Migraine
Cambia (diclofenac potassium) is a non-steroidal anti-inflammatory drug combined with potassium bicarbonate for the treatment of acute migraine with or without aura in adults.
FDA Approval History for Cambia
| Date | Article |
|---|---|
| Jun 23, 2009 |  FDA Approves Cambia for Migraine |
| Dec 12, 2007 | ProEthic Pharmaceuticals Announces Acceptance of PRO-513 New Drug Application for Migraine |
See also...
Cambia (diclofenac potassium) Consumer Information
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
